Adjunctive heparin in moderate to severe ulcerative colitis: a randomised multicentre controlled trial

Completed

• Conditions: Inflammatory bowel disease; Digestive System; Other noninfective gastroenteritis and colitis

• Registration Number: ISRCTN33332764
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients presenting with moderate to severe ulcerative colitis

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The trial aims to assess the time to clinical response, the time to relapse, the health related quality of life of patients and the safety of the two treatment regimens.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration